Is Japan's pharma market a black hole?

Foreign pharma companies began a major push into the Japan market in the 1950s, albeit in the form of joint ventures (JVs) since ownership above 50% was not permitted, writes long-time Japanese industry watcher P Reed Maurer, president of International Alliances Limited, in his exclusive column for The Pharma Letter.

Sixty years later far too many home office executives consider the Japan market a black hole.  This attitude has serious consequences in failing to exploit the benefits of a presence in Japan.

Black hole